Induction of Bladder Cancer in Rats by Fractionated Intravesicular Doses of N-methyl-N-nitrosourea
Overview
Authors
Affiliations
Experiments were conducted to determine the dose response of rat bladder urothelium to a range of different single and fractionated intravesicular doses of the carcinogen, N-methyl-N-nitrosourea (MNU). A dose-related response of bladder-tumour incidence to single graded doses of MNU was found, and a threshold does suitable for use of multistage carcinogenesis experiments was derived from these data. For any given total dose of MNU, the tumour incidence was greater if the MNU had been administered in several small fractions than if it had been administered in fewer larger ones. Extending the interval between doses did not reduce the tumour incidence. It is argued that these results support the multistage theory of carcinogenesis. The histopathology and cell-surface alterations which characterize the development of MNU-induced bladder cancer are described and the contribution of hyperplasia and calculi are discussed.
Bracken fern-induced bladder tumors in guinea pigs. A model for human neoplasia.
Bringuier P, Piaton E, Berger N, Debruyne F, Perrin P, Schalken J Am J Pathol. 1995; 147(3):858-68.
PMID: 7545876 PMC: 1870983.
The induction of urothelial hyperplasia by methyl methanesulphonate and ethyl methanesulphonate.
Tudor R, Severs N, Hicks R Br J Cancer. 1983; 48(2):289-300.
PMID: 6882667 PMC: 2011443. DOI: 10.1038/bjc.1983.184.
Effect of promoters on incidence of bladder cancer in experimental animal models.
Hicks R Environ Health Perspect. 1983; 50:37-49.
PMID: 6873029 PMC: 1569250. DOI: 10.1289/ehp.835037.
The "promoting" activity of methyl methanesulphonate in rat bladder carcinogenesis.
Tudor R, Severs N, Hicks R Br J Cancer. 1984; 50(1):63-75.
PMID: 6743515 PMC: 1976922. DOI: 10.1038/bjc.1984.140.
Kunze E, Gassner G J Cancer Res Clin Oncol. 1986; 112(1):11-8.
PMID: 3733862 DOI: 10.1007/BF00394932.